Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study - DʼAlessio, A; Fulgenzi, C; Nishida, N (Hepatology, 2022)
et al.